| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/23/1997 | EP0785267A1 Valyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785266A1 Arginyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785265A1 Aspartyl tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785264A1 Lencyl t-RNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785263A1 Tryptophanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785262A1 Phenylalanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785261A1 Glutamyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785260A1 Alanyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785259A1 Asparaginyl t-RNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785258A1 Staphylococcus aureus tyrosyl-tRNA synthetase |
| 07/23/1997 | EP0785257A1 Cysteinyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0784983A2 Use of extracellular hemoglobin |
| 07/23/1997 | EP0784691A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating |
| 07/23/1997 | EP0784677A1 Inhibitor of stem cell proliferation and uses thereof |
| 07/23/1997 | EP0784672A1 Human inositol monophosphatase h1 |
| 07/23/1997 | EP0784628A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
| 07/23/1997 | EP0784483A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 07/23/1997 | EP0784478A1 Inhibition of endothelin-1 to reduce inflammatory processes |
| 07/23/1997 | EP0784477A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 07/23/1997 | EP0784476A1 Treatment of multiple sclerosis (ms) and other demyelinating conditions using lofepramine in combination with l-phenylalanine, tyrosine or tryptophan and possibly a vitamin b 12? compound |
| 07/23/1997 | EP0784472A1 Agent for treating papilloma virus-positive malignant and premalignant lesions |
| 07/23/1997 | EP0784471A2 Multi-faceted method to repress reproduction of latent viruses in humans and animals |
| 07/23/1997 | EP0784429A1 Method and formulation of stimulating nitric oxide synthesis |
| 07/23/1997 | EP0531341B1 Use of leukoregulin for the treatment of animals infected with an envelope-virus |
| 07/22/1997 | US5650442 Use of nitric oxide releasing compounds as hypoxic cell radiation sensitizers |
| 07/22/1997 | US5650440 Method of using citramalic acid for treating wrinkles |
| 07/22/1997 | US5650437 Method of using benzilic acid for treating wrinkles |
| 07/22/1997 | US5650436 Method of using galactonic acid or galactonolactone for treating wrinkles |
| 07/22/1997 | US5650425 Anticarcinogenic, antagonist, antitumor agents and antiinflammatory agents |
| 07/22/1997 | US5650397 Polyether antibiotic with nitro-p-diaminobenzene and benzimidazole |
| 07/22/1997 | US5650386 Compositions for oral delivery of active agents |
| 07/22/1997 | US5650280 Cellubrevin homolog |
| 07/22/1997 | US5650145 Dermatological/cosmetic compositions comprising antifungal and antibacterial compounds and reduction of hair loss therewith |
| 07/17/1997 | WO1997025068A2 Mesothelin antigen and methods and kits for targeting it |
| 07/17/1997 | WO1997025066A1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
| 07/17/1997 | WO1997025065A1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent |
| 07/17/1997 | WO1997025064A1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a nsaid |
| 07/17/1997 | WO1997025063A1 Compositions including calcium influx blockers for inhibiting cell growth |
| 07/17/1997 | WO1997025055A1 Nisin in combination with glycerol monolaurate active against helicobacter |
| 07/17/1997 | WO1997025044A1 Topoisomerase ii poison and bis-dioxypiperazine derivative combination therapy |
| 07/17/1997 | WO1997025042A1 Use of an agonist of ppar-alpha and ppar-gamma for the treatment of syndrom x |
| 07/17/1997 | WO1997025025A1 Combination injection preparation |
| 07/17/1997 | CA2242866A1 Compositions including calcium influx blockers for inhibiting cell growth |
| 07/17/1997 | CA2242632A1 Use of an antagonist of ppar-alpha and ppar-gamma for the treatment of syndrome x |
| 07/17/1997 | CA2242364A1 Combination injection preparation |
| 07/16/1997 | EP0783894A1 Antibodies modified at two separate sites |
| 07/16/1997 | EP0783886A2 Use of taxol for the manufacture of a medicament for the treatment of cancer |
| 07/16/1997 | EP0783885A2 Use of taxol for the manufacture of a medicament for the treatment of cancer |
| 07/16/1997 | EP0783884A1 Preventive and remedy for diarrhea |
| 07/16/1997 | EP0783693A1 In vitro models of cns function and dysfunction |
| 07/16/1997 | EP0783577A1 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 07/16/1997 | EP0783574A1 Method for detection of malfolded protein |
| 07/16/1997 | EP0783526A1 Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites |
| 07/16/1997 | EP0783320A1 Protection of hemopoietic cells during chemotherapy or radiotherapy |
| 07/16/1997 | EP0783292A1 Inhibition of hair growth |
| 07/15/1997 | US5648397 Antibiotic, antihistamine, topical |
| 07/15/1997 | US5648395 Method of using tartaric acid for treating wrinkles |
| 07/15/1997 | US5648391 Method of using galacturonic acid or galacturonolactone for treating wrinkles |
| 07/15/1997 | US5648388 Method of using methyllactic acid for treating wrinkles |
| 07/15/1997 | US5648380 Anti-inflammatory wound healing compositions and methods for preparing and using same |
| 07/15/1997 | US5648375 Use of hydrophobic compounds and anesthetics in combination with allosteric hemoglobin modifiers |
| 07/15/1997 | US5648373 CoA-IT and PAF inhibitors |
| 07/15/1997 | US5648238 Human protein kinase C inhibitor homolog |
| 07/10/1997 | WO1997024441A1 Nucleic acids encoding interferon gamma inducing factor-2 |
| 07/10/1997 | WO1997024143A1 Cytotoxic agents |
| 07/10/1997 | WO1997024123A1 Use of polyamine site antagonist for the manufacture of a medicament for the treatment of ischemic disorders of the eye |
| 07/10/1997 | WO1997024121A1 Antiviral agent |
| 07/10/1997 | WO1997024116A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY |
| 07/10/1997 | CA2241913A1 Use of polyamine site antagonist for the manufacture of a medicament for the treatment of ischemic disorders of the eye |
| 07/10/1997 | CA2241758A1 Methods of treatment with compounds having rar.alpha. receptor specific or selective activity |
| 07/10/1997 | CA2241213A1 Antiviral agent |
| 07/10/1997 | CA2238885A1 Nucleic acids encoding interferon gamma inducing factor-2 |
| 07/09/1997 | EP0782456A1 Conjugate consisting of an active substance and a non-exogenous native protein |
| 07/09/1997 | EP0782451A1 Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor |
| 07/09/1997 | EP0782450A1 Use of aromatase inhibitors in the preparation of a drug for treating a relative androgen deficiency in men |
| 07/09/1997 | EP0782441A1 Pharmaceutical control of inflammation |
| 07/09/1997 | CN1154067A Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri |
| 07/08/1997 | US5646190 Acne treating-wound healing compositions and methods for preparing and using same |
| 07/08/1997 | US5646160 Method of treating hyperproliferative vascular disease with rapamycin and mycophenolic acid |
| 07/08/1997 | US5646135 Method for controlling coccidiosis |
| 07/08/1997 | US5646116 Administering insulin-like growth factor i to a mammal |
| 07/08/1997 | US5645988 Methods of identifying drugs with selective effects against cancer cells |
| 07/08/1997 | US5645852 Butyric ester cyto-differtiating agents |
| 07/08/1997 | US5645839 Combined use of angiotensin inhibitors and nitric oxide stimulators to treat fibrosis |
| 07/03/1997 | WO1997023632A1 A LONG QT SYNDROME GENE WHICH ENCODES KVLQT1 AND ITS ASSOCIATION WITH minK |
| 07/03/1997 | WO1997023628A1 Staphylococcus aureus coenzyme a disulfide reductase, and inhibitors thereof useful as antimicrobial agents |
| 07/03/1997 | WO1997023625A1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
| 07/03/1997 | WO1997023622A1 Novel tcts response regulator of staphylococcus aureus |
| 07/03/1997 | WO1997023620A1 Novel tcts response regulator of staphylococcus aureus |
| 07/03/1997 | WO1997023598A2 A long qt syndrome gene which encodes kvlqt1 and its association with mink |
| 07/03/1997 | WO1997023505A1 Two component signal transducing system protein from staphylococcus aureus |
| 07/03/1997 | WO1997023500A1 Endothelial cell proliferation inhibitor and method of use |
| 07/03/1997 | WO1997023225A1 Combinations of dp and fp type prostaglandins for lowering iop |
| 07/03/1997 | WO1997023218A1 A process for regulating vagal tone |
| 07/03/1997 | WO1997023204A1 Nitric oxide (no) synthase inhibitor to treat or prevent type ii diabetes |
| 07/03/1997 | WO1997023203A1 Aminoguanidine for treating niddm |
| 07/03/1997 | WO1997016185A3 A pharmaceutical composition for the treatment of autoimmune diseases |
| 07/03/1997 | WO1997011692A3 Protein tyrosine kinase inhibitors for treating osteoarthritis |
| 07/03/1997 | WO1997002046A3 Saccharide conjugates |
| 07/03/1997 | CA2241105A1 Staphylococcus aureus coenzyme a disulfide reductase, and inhibitors thereof useful as antimicrobial agents |